UM Ventures is an ambitious joint research commercialization effort of the University Maryland Baltimore and College Park.
Launched in 2012 by the University System of Maryland Board of Regents and the Governor of Maryland, University of Maryland Ventures (UM Ventures) is accelerating technology commercialization and advancing industry collaboration by integrating the entrepreneurial programs of the University of Maryland, Baltimore and College Park.
06/30/2020
University of Maryland School of Medicine Official Page Dr. Gammie’s latest invention, the device for cardiac surgery, is making strides. Early-stage and follow-on investment from UM Ventures helps University of Maryland, Baltimore startups advance their tech and attract other investors. https://www.protaryx.com/2020/06/protaryx-medical-announces-$8-3m-in-funding/
06/16/2020
Commercializing a medical device can take decades. Learn about Breethe’s journey from John Wu, the engineer and co-inventor of Breethe’s technology, and Phil Robilotto, head of technology transfer University of Maryland, Baltimore. https://www.umventures.org/news/concept-exit-words-wisdom-co-inventor-and-umb-tech-transfer-leader
05/18/2020
ICYMI: University of Maryland School of Medicine Official Page faculty are working with the Maryland Development Center to develop a small, inexpensive portable ventilator for patients whose lungs are severely damaged from pneumonia. Learn more umventures.org
05/15/2020
ICYMI: University of Maryland School of Medicine Official Page & A. James Clark School of Engineering researchers are developing a device that essentially turns the abdomen into a "third lung” & are hustling to make it available for patients. Investment opportunities are available. Learn more umventures.org
05/14/2020
ICYMI: University of Maryland School of Medicine Official Page's Jospeh Scalea is working on an automated blood draw solution that could help protect medical providers in the fight against . University of Maryland, Baltimore is providing seed funding, but investment opportunities are available. Learn more umventures.org
05/13/2020
ICYMI: University of Maryland School of Medicine Official Page Dr. Chaz Hong's research team invented & is testing a preclinical drug treatment for respiratory ailments, including acute lung injuries & . University of Maryland, Baltimore is helping fast-track projects like this w potential matching investments. umventures.org
05/12/2020
ICYMI: GEn1e Lifesciences, is developing a therapeutic drug treatment for based on licensed from University of Maryland, Baltimore After a $3M raise, they are looking for additional investors to speed up the fight against . Learn more umventures.org
ICYMI: University of Maryland, Baltimore and University of Maryland are backing technologies and research in the fight against . Learn more about our innovative solutions and investment opportunities at
UM Ventures - MPowering the State | UMB UM Ventures is a joint initiative of the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technologies and expand industry collaboration.
University of Maryland, Baltimore and University of Maryland are backing technologies and research in the fight against . Learn more about our innovative solutions and investment opportunities at
UM Ventures - MPowering the State | UMB UM Ventures is a joint initiative of the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technologies and expand industry collaboration.
05/06/2020
University of Maryland School of Medicine Official Page faculty are working with the Maryland Development Center to develop a small, inexpensive portable ventilator for patients whose lungs are severely damaged from pneumonia. Learn more umventures.org
05/05/2020
University of Maryland School of Medicine Official Page & A. James Clark School of Engineering researchers are developing a device that essentially turns the abdomen into a "third lung” & are hustling to make it available for patients. Investment opportunities are available. Learn more umventures.org
05/04/2020
University of Maryland School of Medicine Official Page's Dr. Bartley Griffith has dedicated most of his career to finding a better solution for patients suffering from respiratory disease & lung failure. Abiomed's acquisition of Breethe brings his quest closer to reality. Read more at umventures.org